Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2900
Peer-review started: May 8, 2015
First decision: August 26, 2015
Revised: September 8, 2015
Accepted: November 9, 2015
Article in press: November 9, 2015
Published online: March 14, 2016
Processing time: 310 Days and 9.8 Hours
Gastric cancer is one of the most common human malignancies, and its prevalence has been shown to be well-correlated with cancer-related deaths worldwide. Regrettably, the poor prognosis of this disease is mainly due to its late diagnosis at advanced stages after the cancer has already metastasized. Recent research has emphasized the identification of cancer biomarkers in the hope of diagnosing cancer early and designing targeted therapies to reverse cancer progression. One member of a family of growth-related nicotinamide adenine dinucleotide (NADH or hydroquinone) oxidases is tumor-associated NADH oxidase (tNOX; ENOX2). Unlike its counterpart CNOX (ENOX1), identified in normal rat liver plasma membranes and shown to be stimulated by growth factors and hormones, tNOX activity purified from rat hepatoma cells is constitutively active. Its activity is detectable in the sera of cancer patients but not in those of healthy volunteers, suggesting its clinical relevance. Interestingly, tNOX expression was shown to be present in an array of cancer cell lines. More importantly, inhibition of tNOX was well correlated with reduced cancer cell growth and induction of apoptosis. RNA interference targeting tNOX expression in cancer cells effectively restored non-cancerous phenotypes, further supporting the vital role of tNOX in cancer cells. Here, we review the regulatory role of tNOX in gastric cancer cell growth.
Core tip: Gastric cancer is one of the most common human malignancies, and its prevalence has been shown to be well-correlated with cancer-related deaths worldwide. Here, we review the role of tumor-associated NADH oxidase tNOX (ENOX2) in cancer, in particular its regulation of gastric cancer cell growth. The most common inhibitors of tNOX and the phenotypes associated with tNOX depletion are also discussed.
- Citation: Cheng HL, Lee YH, Yuan TM, Chen SW, Chueh PJ. Update on a tumor-associated NADH oxidase in gastric cancer cell growth. World J Gastroenterol 2016; 22(10): 2900-2905
- URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2900.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i10.2900
According to Global Cancer Statistics, nearly 1 million new gastric cancer cases and more than 700000 gastric cancer-associated death were reported in 2012[1]. Unfortunately, despite progression in the diagnosis and treatment of advanced gastric cancer, many patients suffer from metastasis and later recurrence of this disease. Thus, their poor prognosis reflects the fact that gastric cancers are often diagnosed at an advanced stage. Current research efforts have focused on available diagnostic and prognostic biomarkers of gastric cancer. For example, carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) have been used as standard biomarkers for gastric cancer diagnosis[2]. A method for detecting circulating tumor cells in gastric cancer patients, which could provide important targets for treatment and critical surrogate markers, is also being developed[3]. Moreover, polymorphisms of certain genes, such as epidermal growth factor receptor (EGFR), have been used as risk markers for gastric cancer[4]. Serum level of interleukin-18 (IL-18), which plays a role in the pathogenesis of malignancies and is a determinant of clinical outcome in gastric cancer patients, is another risk marker[5]. Recent studies have revealed that several microRNAs, when abnormally expressed, are potential biomarkers of gastric cancer[6]. Although intensive efforts to identify biomarkers in this field are ongoing, universal biomarkers for gastric cancer are scarce because of the heterogeneous properties of this cancer[2]. Thus, new and specific gastric cancer markers for diagnoses and therapeutic purpose are urgently needed.
We have previously described tumor-associated NADH oxidase (tNOX, also known as ENOX2), a member of a family of growth-related NADH (or hydroquinone) oxidases[7-10]. Unlike its counterpart CNOX (ENOX1), identified in normal rat liver plasma membranes and shown to be stimulated by growth factors and hormones, tNOX activity purified from rat hepatoma cells is unresponsive to growth stimuli and is instead constitutively active[7]. Subsequent studies have confirmed that tNOX is present in an array of cancer cell lines, including those derived from breast, cervix, colon, and lung cancer as well as leukemias[11-14]. Its activity is also observed in the sera of cancer patients but not in those of healthy volunteers, suggesting its clinical relevance[15-17]. tNOX cDNA was subsequently cloned from a HeLa cell cDNA library[9], and functional motifs of tNOX protein have been identified. The important role of tNOX in cell growth regulation is supported by a study that showed that the growth rate of mouse embryo fibroblasts (MEFs) from tNOX-overexpressing transgenic mice is approximately twice that of wild-type cells[18]. Given its expression in an array of cancer cell lines and presence in sera of cancer patients, taken together with other characteristics discussed below, tNOX possesses potential as a biomarker. Here, we briefly review the regulatory role of tNOX in gastric cancer cell growth.
Although tNOX expression has been demonstrated in an array of cancer cell lines, there is relatively less information regarding tNOX protein expression in gastric cancer cells. To demonstrate the expression of tNOX protein in gastric cancer cells, we utilized cell lines derived from human stomach cancers, including AGS (gastric adenocarcinoma), TMC-1 (derived from the lymph node of a moderately differentiated stomach adenocarcinoma), MKN45 (from the lymph node of a moderately differentiated stomach adenocarcinoma), SNU-1 (from a poorly differentiated primary carcinoma of the stomach), TMK-1 (from a poorly differentiated adenocarcinoma), and SCM (human gastric carcinoma) cells. Western blot analyses showed that tNOX protein was expressed to varying degrees in all gastric cancer lines (Figure 1). tNOX expression was higher in TMC-1, SCM, and TMK-1 cells than in SNU-1, MKN45, and AGS cells. Antisera used in western blot analyses were raised against bacterial tNOX, as described previously[12], and they recognized the same tNOX protein band as that identified by a commercially available anti-tNOX polyclonal antibody[14] (Protein Tech Group, Inc. Chicago, IL, United States).
We also continuously monitored cell growth dynamics, measured as cell impedance and displayed in the form of cell index (CI) values[19-22]. In this application of the cell impedance assay, the existence of cells on top of the electrodes creates an increase in electrode impedance, the degree of which is determined by cell numbers and the level of cell adhesion. By comparing the results from cell-impedance measurements with those obtained with various commonly used cytotoxicity assays, we confirmed that this novel measurement of electrical impedance provides an effective, continuous-monitoring method for examining cellular processes in a dye-free setting[23,24]. Using this approach, we found that both SCM and AGS cell grew much faster than MKN45 and TMC-1 cells (Figure 2). Surprisingly, the growth rate of TMC-1 cells, as determined using this method, was slower, notwithstanding the fact that they were derived from patients with metastatic stomach cancer. It has been reported that TMC-1 cells grown in vitro exist as a mixture of attached and suspended cells[25]. Thus, since the degree of cell impedance is determined by both cell numbers and the level of cell adhesions, the cell impedance method used here may yield a CI value that underestimates the number of TMC-1 cells.
Numerous chemopreventive and anti-cancer drugs have been shown to reduce tNOX activity accompanied by a decrease in cell growth. These agents include capsaicin, the major component of chili pepper[11], (-)-epigallocatechin-3-gallate (EGCg)[26], phenoxodiol[27], and doxorubicin (trade name, Adriamycin)[28,29]. Interesting, these chemopreventive agents, often used to reverse cancer progression, preferentially inhibit tNOX activity in cancer cells, reducing cancer cell growth but having little effect on non-cancerous cells[11,26]. This is important, since the dietary pattern and availability of fresh fruits and vegetables as well as gastric cancer incidence differ greatly among countries. Statistical data bear this out, showing that South Korea, Mongolia, Japan, and China in Eastern Asia have the highest incidence rates of gastric cancer, whereas Northern America and most parts of Africa have the lowest rate[1]. Recent progress has focused on the chemopreventive effects of capsaicin, reflecting its anti-growth activity against various human cancer cell systems, including prostate[30-32], colon[33,34], hepatoma[35,36], breast[11,37] cancer, as well as leukemic[38-40]. However, there are few studies available reporting on the cytotoxicity of capsaicin in gastric cancer cells[41-43].
We have investigated the effects of capsaicin on different gastric cancer cell lines, including SCM, SNU-1, and TMC-1. In these studies, which measured metabolic activity by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assays, we verified that capsaicin exerted a concentration-dependent inhibitory effect on SCM cell proliferation. After 24 h exposure, 100 μmol/L and 200 μmol/L capsaicin decreased SCM cell viability to less than 70% and 50% of control groups, respectively. Cell proliferation, measured by counting SCM cell number, was also significantly decreased in a concentration and time-dependent manner by capsaicin exposure[44]. We studied the anticancer activity of capsaicin on the proliferation of SNU-1 cells, which were derived from a poorly differentiated human gastric carcinoma, and TMC-1 cells, a metastatic gastric carcinoma line[45]. These assays showed that capsaicin induced significant cytotoxicity in SNU-1 cells at 100 μmol/L, diminishing cell numbers to smaller than 40% and 30% of control groups after 48 and 72 h exposure, respectively. To our surprise, 100 μmol/L capsaicin did not decrease the number of TMC-1 cells, even after a 72 h exposure[45]. These results imply that capsaicin exerted differential cytotoxic effects on gastric cancer lines derived from different stages of cancer progression.
To further investigate whether the differential inhibitory effects of capsaicin on cell growth inhibition involves cell death, specifically apoptosis, we analyzed cells for apoptotic subpopulations using flow cytometry. Interestingly, capsaicin provoked cytotoxicity in SCM cells concurrently with caspase 3-mediated poly (ADP-ribose) polymerase (PARP) cleavage and apoptosis induction[44]. Using the pan-caspase inhibitor Z-VAD-FMK, we confirmed that capsaicin-induced apoptosis in these cells was dependent on caspase activity[44]. Consistent with results obtained in other gastric cancer cell lines, capsaicin was found to induce cytotoxicity and apoptosis in SNU-1 cells, possibly through up-regulation of p53[42]. We also demonstrated that 100 and 200 μmol/L capsaicin triggered apoptosis in 16.1% and 26.2% of SNU-1 cells, respectively[45]. In contrast, TMC-1 cells were fundamentally unresponsive to the apoptotic effect of capsaicin; exhibiting very little apoptosis in response to capsaicin exposure. The greater cytotoxicity of capsaicin toward SCM and SNU-1 cells was also reflected in the apoptotic activity of capsaicin in these two lines, whereas capsaicin induced neither cytotoxicity nor apoptosis in TMC-1 cells.
To identify molecular mechanisms underlying the differential cytotoxicity of capsaicin in gastric cancer cells, we assessed mitochondrial function, by measuring 3,3’-dihexyloxacarbocyanine iodide [DiOC6(3)] retention. We showed that capsaicin instigated changes in mitochondrial membrane potential in SNU-1 cells but not in TMC-1 cells[45]. Further protein analyses confirmed that capsaicin up-regulated pro-apoptotic Bak protein and down-regulated anti-apoptosis Bcl-2 protein in SNU-1 cells, whereas these changes were less prominent in TMC-1 cells[45].
Given that capsaicin-induced cytotoxicity and inhibition of tNOX activity was previously established in cancer/transformed cells[11], we next tested the possibility that tNOX protein is involved in the differential effects of capsaicin in these two gastric cancer lines. Interestingly, we found that capsaicin enhanced tNOX down-regulation in SCM cells concurrently with capsaicin-induced apoptosis[44]. Additionally, in SNU-1 cells, capsaicin-induced tNOX down-regulation was accompanied by a concentration-dependent increase in caspase 3-mediated PARP cleavage and apoptosis[45]. In contrast, capsaicin treatments promoted very slight changes in tNOX expression or caspase 3-directed PARP cleavage in TMC-1 cells, resulting in limited apoptosis. These various lines of evidences indicate that tNOX is a potential molecular target for capsaicin in gastric cancer cells that is important for gastric cancer survival.
To examine whether tNOX expression level is crucial for the survival of gastric cancer cells, we knocked down tNOX expression in TMC-1 cells using small interfering (hairpin) RNA (shRNA). These tNOX-depleted TMC-1 cells were more responsive to capsaicin treatments, as evidenced by enhanced caspase 3-mediated PARP cleavage, greater loss of mitochondrial membrane potential, and higher intracellular oxidative stress level compared with control groups[45]. Thus, decreased tNOX expression in TMC-1 cells resulted in greater sensitivity to the effects of capsaicin. Interestingly, reduced expression of tNOX appeared to affect cell-cycle progression such that capsaicin-induced G1 accumulation was enhanced and proliferation was reduced in tNOX-depleted TMC-1 cells[45], supporting a significant role for tNOX in TMC-1 cell growth.
We also examined the possibility that decreasing tNOX protein levels in cancer cells is sufficient to diminish tumor growth in animals. To this end, mice were injected with parental (wild type) HCT116 human colon cancer and either control (scrambled RNAi) HCT116 cells or tNOX-knockdown HCT116 cells, and xenograft tumors were examined after 60 d. We found that the growth of HCT116 xenograft tumors was significantly reduced in tNOX-knockdown groups[46], indicating that tNOX depletion in cancer cells reduces their capacity to form tumors in vivo.
The regulatory role of tNOX in cell growth is not limited to gastric cancer cells. Utilizing a loss-of-function approach, Chueh et al[47] reduced tNOX expression in HeLa cervical cancer cells using antisense oligonucleotides and found that tNOX deficiency reduced cell proliferation, as determined by colony-formation assays. A subsequent study utilizing shRNA to specifically and effectively inhibit tNOX expression in HeLa cells showed that tNOX knockdown attenuated cell proliferation and migration by interfering with the Rac pathway[14]. In another study, tNOX-knockdown was shown to sensitize cells to stress-induced apoptosis in human HEK293 cells derived from human embryonic tissues[13], which share properties with cancer. Notably, we found that tNOX is abundantly expressed in these embryonic cells. Conversely, a gain-of-function approach showed that tNOX overexpression in non-cancerous MCF-10A cells gave rise to enhanced invasiveness, an aggressive feature of cancer cells, confirming a vital role for tNOX in cancer progression[47]. Moreover, transient up-regulation of tNOX in HCT116 cells augmented cell proliferation and migration in vitro and in vivo[46]. These phenomena were also observed in A549 human lung cancer cells, demonstrating that an epithelial-to-mesenchymal transition mechanism may be involved in the enhanced cell migration associated with tNOX up-regulation[22].
In this review, we summarized the recent literature on the biological function of tNOX in gastric cancer cells. We also considered the paradoxical effect of capsaicin on cancer growth and tNOX expression, which results in differential cellular outcomes. Collectively, these various lines of evidence establish a significant regulatory role for tNOX in cancer cell proliferation, survival, and migration. This information may provide a reasonable framework for the future development of tNOX-targeting agents as a new class of anti-tumor therapeutics.
P- Reviewer: Irato P S- Editor: Gong ZM L- Editor: Filipodia E- Editor: Zhang DN
1. | Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 18694] [Cited by in F6Publishing: 21024] [Article Influence: 2336.0] [Reference Citation Analysis (2)] |
2. | Jin Z, Jiang W, Wang L. Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review). Oncol Lett. 2015;9:1502-1508. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 64] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis (0)] |
3. | Kolostova K, Matkowski R, Gürlich R, Grabowski K, Soter K, Lischke R, Schützner J, Bobek V. Detection and cultivation of circulating tumor cells in gastric cancer. Cytotechnology. 2015;Epub ahead of print. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis (0)] |
4. | Torres-Jasso JH, Marín ME, Santiago-Luna E, Leoner JC, Torres J, Magaña-Torres MT, Perea FJ, Ibarra B, Sánchez-López JY. EGFR gene polymorphisms -216G>T and -191C>A are risk markers for gastric cancer in Mexican population. Genet Mol Res. 2015;14:1802-1807. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
5. | Tas F, Tilgen Yasasever C, Karabulut S, Tastekin D, Duranyildiz D. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer. Biomed Pharmacother. 2015;70:19-23. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis (0)] |
6. | Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol. 2014;20:12007-12017. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 87] [Article Influence: 8.7] [Reference Citation Analysis (0)] |
7. | Bruno M, Brightman AO, Lawrence J, Werderitsh D, Morré DM, Morre DJ. Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranes. Biochem J. 1992;284:625-628. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 70] [Cited by in F6Publishing: 80] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
8. | Chueh PJ. Cell membrane redox systems and transformation. Antioxid Redox Signal. 2000;2:177-187. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
9. | Chueh PJ, Kim C, Cho N, Morré DM, Morré DJ. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. Biochemistry. 2002;41:3732-3741. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 3.8] [Reference Citation Analysis (0)] |
10. | Jiang Z, Gorenstein NM, Morré DM, Morré DJ. Molecular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (NADH) oxidase. Biochemistry. 2008;47:14028-14038. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
11. | Morré DJ, Chueh PJ, Morré DM. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA. 1995;92:1831-1835. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 228] [Cited by in F6Publishing: 207] [Article Influence: 7.1] [Reference Citation Analysis (0)] |
12. | Chen CF, Huang S, Liu SC, Chueh PJ. Effect of polyclonal antisera to recombinant tNOX protein on the growth of transformed cells. Biofactors. 2006;28:119-133. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
13. | Mao LC, Wang HM, Lin YY, Chang TK, Hsin YH, Chueh PJ. Stress-induced down-regulation of tumor-associated NADH oxidase during apoptosis in transformed cells. FEBS Lett. 2008;582:3445-3450. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
14. | Liu SC, Yang JJ, Shao KN, Chueh PJ. RNA interference targeting tNOX attenuates cell migration via a mechanism that involves membrane association of Rac. Biochem Biophys Res Commun. 2008;365:672-677. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
15. | Chueh PJ, Morré DJ, Wilkinson FE, Gibson J, Morré DM. A 33.5-kDa heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients. Arch Biochem Biophys. 1997;342:38-47. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 1.6] [Reference Citation Analysis (0)] |
16. | Morré DJ, Caldwell S, Mayorga A, Wu LY, Morré DM. NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch Biochem Biophys. 1997;342:224-230. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
17. | Morré DJ, Reust T. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N’-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients. J Bioenerg Biomembr. 1997;29:281-289. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
18. | Yagiz K, Wu LY, Kuntz CP, James Morré D, Morré DM. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype. J Cell Biochem. 2007;101:295-306. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
19. | Ke N, Wang X, Xu X, Abassi YA. The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol. 2011;740:33-43. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 281] [Cited by in F6Publishing: 289] [Article Influence: 22.2] [Reference Citation Analysis (0)] |
20. | Moela P, Choene MM, Motadi LR. Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises breast cancer cells MCF7 to staurosporine and camptothecin-induced cell death. Immunobiology. 2014;219:593-601. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis (0)] |
21. | Kuo YF, Su YZ, Tseng YH, Wang SY, Wang HM, Chueh PJ. Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells. Free Radic Biol Med. 2010;49:214-226. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 7.6] [Reference Citation Analysis (0)] |
22. | Su YC, Lin YH, Zeng ZM, Shao KN, Chueh PJ. Chemotherapeutic agents enhance cell migration and epithelial-to-mesenchymal transition through transient up-regulation of tNOX (ENOX2) protein. Biochim Biophys Acta. 2012;1820:1744-1752. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis (0)] |
23. | Chuang SM, Lee YH, Liang RY, Roam GD, Zeng ZM, Tu HF, Wang SK, Chueh PJ. Extensive evaluations of the cytotoxic effects of gold nanoparticles. Biochim Biophys Acta. 2013;1830:4960-4973. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 6.6] [Reference Citation Analysis (0)] |
24. | Chueh PJ, Liang RY, Lee YH, Zeng ZM, Chuang SM. Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. J Hazard Mater. 2014;264:303-312. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 106] [Cited by in F6Publishing: 92] [Article Influence: 9.2] [Reference Citation Analysis (0)] |
25. | Shyu RY, Jiang SY, Jong YJ, Cheng KC, Lin CH, Yu JC, Wu MF, Chang TM. Establishment and characterization of a human gastric carcinoma cell line TMC-1. Cells Tissues Organs. 2004;177:37-46. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
26. | Morré DJ, Bridge A, Wu LY, Morré DM. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol. 2000;60:937-946. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 2.9] [Reference Citation Analysis (0)] |
27. | Morré DJ, Chueh PJ, Yagiz K, Balicki A, Kim C, Morré DM. ECTO-NOX target for the anticancer isoflavene phenoxodiol. Oncol Res. 2007;16:299-312. [PubMed] [Cited in This Article: ] |
28. | Morré DJ, Kim C, Paulik M, Morré DM, Faulk WP. Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin? J Bioenerg Biomembr. 1997;29:269-280. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
29. | Hedges KL, Morré DM, Wu LY, Morre DJ. Adriamycin tolerance in human mesothelioma lines and cell surface NADH oxidase. Life Sci. 2003;73:1189-1198. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
30. | Mori A, Lehmann S, O’Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler HP. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res. 2006;66:3222-3229. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 245] [Cited by in F6Publishing: 214] [Article Influence: 11.9] [Reference Citation Analysis (0)] |
31. | Sánchez AM, Sánchez MG, Malagarie-Cazenave S, Olea N, Díaz-Laviada I. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis. 2006;11:89-99. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 143] [Cited by in F6Publishing: 138] [Article Influence: 8.1] [Reference Citation Analysis (0)] |
32. | Sánchez AM, Malagarie-Cazenave S, Olea N, Vara D, Chiloeches A, Díaz-Laviada I. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis. 2007;12:2013-2024. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 119] [Cited by in F6Publishing: 91] [Article Influence: 5.4] [Reference Citation Analysis (0)] |
33. | Kim CS, Park WH, Park JY, Kang JH, Kim MO, Kawada T, Yoo H, Han IS, Yu R. Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food. 2004;7:267-273. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 4.1] [Reference Citation Analysis (0)] |
34. | Kim YM, Hwang JT, Kwak DW, Lee YK, Park OJ. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann N Y Acad Sci. 2007;1095:496-503. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 4.5] [Reference Citation Analysis (0)] |
35. | Baek YM, Hwang HJ, Kim SW, Hwang HS, Lee SH, Kim JA, Yun JW. A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics. 2008;8:4748-4767. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
36. | Lee YS, Kang YS, Lee JS, Nicolova S, Kim JA. Involvement of NADPH oxidase-mediated generation of reactive oxygen species in the apototic cell death by capsaicin in HepG2 human hepatoma cells. Free Radic Res. 2004;38:405-412. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 3.0] [Reference Citation Analysis (0)] |
37. | Kang HJ, Soh Y, Kim MS, Lee EJ, Surh YJ, Kim HR, Kim SH, Moon A. Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in ras-transformed human breast epithelial cells. Int J Cancer. 2003;103:475-482. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 3.4] [Reference Citation Analysis (0)] |
38. | Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, Segawa K, Ikeda Y, Kizaki M. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 2004;64:1071-1078. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 210] [Cited by in F6Publishing: 189] [Article Influence: 9.5] [Reference Citation Analysis (0)] |
39. | Lawen A, Martinus RD, McMullen GL, Nagley P, Vaillant F, Wolvetang EJ, Linnane AW. The universality of bioenergetic disease: the role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase. Mol Aspects Med. 1994;15 Suppl:s13-s27. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 1.8] [Reference Citation Analysis (0)] |
40. | Wolvetang EJ, Larm JA, Moutsoulas P, Lawen A. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ. 1996;7:1315-1325. [PubMed] [Cited in This Article: ] |
41. | Chow J, Norng M, Zhang J, Chai J. TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells--Mechanisms behind a possible new “hot” cancer treatment. Biochim Biophys Acta. 2007;1773:565-576. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 92] [Cited by in F6Publishing: 101] [Article Influence: 5.9] [Reference Citation Analysis (0)] |
42. | Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, Yu R, Han IS. Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett. 1997;120:235-241. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
43. | Lo YC, Yang YC, Wu IC, Kuo FC, Liu CM, Wang HW, Kuo CH, Wu JY, Wu DC. Capsaicin-induced cell death in a human gastric adenocarcinoma cell line. World J Gastroenterol. 2005;11:6254-6257. [PubMed] [Cited in This Article: ] |
44. | Wang HM, Chueh PJ, Chang SP, Yang CL, Shao KN. Effect of Ccapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells. Biofactors. 2008;34:209-217. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
45. | Wang HM, Chuang SM, Su YC, Li YH, Chueh PJ. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth. Cell Biochem Biophys. 2011;61:355-366. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
46. | Liu NC, Hsieh PF, Hsieh MK, Zeng ZM, Cheng HL, Liao JW, Chueh PJ. Capsaicin-mediated tNOX (ENOX2) up-regulation enhances cell proliferation and migration in vitro and in vivo. J Agric Food Chem. 2012;60:2758-2765. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis (0)] |
47. | Chueh PJ, Wu LY, Morré DM, Morré DJ. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. Biofactors. 2004;20:235-249. [PubMed] [Cited in This Article: ] |